ANELLOBRICKS
Live / Applied — Statement of use — non-final action mailed (as of 08 Jun 2026)
What this means for you
Not registered yet, but its 16 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97269409
- Mark type
- Word mark
- Filed
- 16 Feb 2022
- Published for opposition
- 07 Mar 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of anelloviruses
- Class 042 — Scientific and technological services: Product development for others in the field of biotechnology and development of pharmaceuticals, therapeutic agents, and anelloviruses; research and development of therapeutics related to anelloviruses
Owner
- Ring Therapeutics, Inc., Cambridge, MA, US
- Ring Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 08 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Jun 2026 — NON-FINAL ACTION E-MAILED
- 08 Jun 2026 — SU - NON-FINAL ACTION - WRITTEN
- 09 May 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 04 May 2026 — USE AMENDMENT FILED
- 04 May 2026 — TEAS STATEMENT OF USE RECEIVED
- 28 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Apr 2026 — SOU EXTENSION 5 GRANTED
- 29 Oct 2025 — SOU EXTENSION 5 FILED
- 27 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 01 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2025 — SOU EXTENSION 4 GRANTED
- 30 Apr 2025 — SOU EXTENSION 4 FILED
- 30 Apr 2025 — SOU TEAS EXTENSION RECEIVED